Next generations sequencing (NGS) is definitely one of the most revolution-ary technology of the last years in genetic and medical field (Kricka and Di Resta, 2
Parkinson’s disease (PD) is the second most common neurodegen-erative disease, affecting 1% of the population over 55 years of age and up to 4% of the populati